125 related articles for article (PubMed ID: 10492622)
21. Pharmaceutical application of biomedical polymers. XXIX. Preliminary study on film dosage form prepared from chitosan for oral drug delivery.
Miyazaki S; Yamaguchi H; Takada M; Hou WM; Takeichi Y; Yasubuchi H
Acta Pharm Nord; 1990; 2(6):401-6. PubMed ID: 2095798
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
23. A novel sustained-release formulation of ibuprofen provides effective once-daily therapy in the treatment of rheumatoid arthritis and osteoarthritis.
O'Connor TP; Anderson AM; Lennox B; Muldoon C
Br J Clin Pract; 1993; 47(1):10-3. PubMed ID: 8461240
[TBL] [Abstract][Full Text] [Related]
24. OPTIMIZATION OF THE PREPARATION OF KOLLIDON SR-BASED AMIODARONE HYDROCHLORIDE TABLETS WITH SUSTAINED RELEASE.
Creţeanu A; Tàntaru G; Vieriu M; Panainte AD; Ochiuz L
Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1161-5. PubMed ID: 26793864
[TBL] [Abstract][Full Text] [Related]
25. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
Krauland AH; Guggi D; Bernkop-Schnürch A
J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
[TBL] [Abstract][Full Text] [Related]
26. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
27. [Comparative evaluation using in vitro dissolution tests of various sustained release theophylline preparations].
Kissné CE
Acta Pharm Hung; 1990 Nov; 60(5-6):191-6. PubMed ID: 2087990
[TBL] [Abstract][Full Text] [Related]
28. Sustained Release Bilayer Tablet of Ibuprofen and Phenylephrine Hydrochloride: Preparation and Pharmacokinetics in Beagle Dogs.
Zhu C; Xu S; Han X; Wang W; He W; Yin L; Yang L; Qin C
AAPS PharmSciTech; 2019 Jan; 20(2):86. PubMed ID: 30673916
[TBL] [Abstract][Full Text] [Related]
29. Preparation of an extended-release matrix tablet using chitosan/Carbopol interpolymer complex.
Park SH; Chun MK; Choi HK
Int J Pharm; 2008 Jan; 347(1-2):39-44. PubMed ID: 17662544
[TBL] [Abstract][Full Text] [Related]
30. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
[TBL] [Abstract][Full Text] [Related]
31. Chitosan salts as nasal sustained delivery systems for peptidic drugs.
Cerchiara T; Luppi B; Bigucci F; Zecchi V
J Pharm Pharmacol; 2003 Dec; 55(12):1623-7. PubMed ID: 14738587
[TBL] [Abstract][Full Text] [Related]
32. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers.
Xu X; Sun M; Zhi F; Hu Y
Int J Pharm; 2006 Mar; 310(1-2):139-45. PubMed ID: 16413710
[TBL] [Abstract][Full Text] [Related]
33. Preparation of a prolonged-release tablet formulation of diclofenac sodium. Part 1: Using chitosan.
Acartürk F
Pharmazie; 1989 Aug; 44(8):547-9. PubMed ID: 2594826
[TBL] [Abstract][Full Text] [Related]
34. Bioavailability of ambroxol sustained release preparations. Part I: In vitro dissolution studies.
Alighieri T; Avanessian S; Berlini S; Bianchi SG; Deluigi P; Valducci R; Guelen PJ
Arzneimittelforschung; 1988 Jan; 38(1):92-4. PubMed ID: 3365281
[TBL] [Abstract][Full Text] [Related]
35. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
Emami J; Tavakoli N; Movahedian A
J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
[TBL] [Abstract][Full Text] [Related]
36. Studies of chitosan/Kollicoat SR 30D film-coated tablets for colonic drug delivery.
Fan LF; He W; Chang YZ; Xiang B; Du Q; Wang F; Qin M; Cao DY
Int J Pharm; 2009 Jun; 375(1-2):8-15. PubMed ID: 19457627
[TBL] [Abstract][Full Text] [Related]
37. Rationale for ibuprofen co-administration with antacids: potential interaction mechanisms affecting drug absorption.
Parojcić J; Corrigan OI
Eur J Pharm Biopharm; 2008 Jun; 69(2):640-7. PubMed ID: 18280125
[TBL] [Abstract][Full Text] [Related]
38. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
[TBL] [Abstract][Full Text] [Related]
39. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
Vostalová L; Rabisková M; Medvecká G
Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
[TBL] [Abstract][Full Text] [Related]
40. Fast dispersible/slow releasing ibuprofen tablets.
Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
